AGENDA AT A GLANCE
Day One - Wednesday, September 28
Updates on Your Current Framework for Biomarker & CDx Development
Biomarker Discovery
& Translational Development
Clinical Biomarker Development
CDx Development
Investigating Preclinical Cancer Biology
Managing Increasing Complexity Within the Next Promising Wave of Biomarker Development
Exploring The Scope of Today’s Drug-Dx Co-Development
Biomarker Discovery
& Translational Development
Clinical Biomarker Development
Exploring The Scope of Today’s Drug-Dx Co-Development
Fast-Tracking Promising Biomarker Development By Leveraging Collaborative Industry Resources
Defining Patient Populations
Exploring The Scope of Today’s Drug-Dx Co-Development
Alignment in Biomarker Development in an Increasingly Complex Biological Landscape
Day Two - Thursday, September 29
Establishing a Footprint in Competitive Global Markets
Biomarker Discovery
& Translational Development
Clinical Biomarker Development
CDx Commercialization
Tools & Techniques Driving Efficiencies in Biomarker Discovery
Gaining a Strategic Advantage Through the Implementation of Latest Patient Stratification Approaches
Creating & Maintaining Strong Market Access & Reimbursement Strategies
Biomarker Discovery
& Translational Development
Clinical Biomarker Development
CDx Commercialization
Next Generation Biomarker Discovery
Earlier Intervention for Better Patient Outcomes
Ensuring Access in Routine Practice